Denali Therapeutics Inc. (DNLI) vs Dyne Therapeutics, Inc. (DYN)

A side-by-side comparison of Denali Therapeutics Inc. and Dyne Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DNLI vs DYN

growth of $100 · dividends reinvested · last 6y
DNLI -47.9% (-10.3%/yr)DYN -35.4% (-7.0%/yr)DYN compounded faster over this window
50100150200Start $100202120222023202420252026$52$65
DNLI DYN

DNLI vs DYN: by the numbers

  • •DNLI is the larger company ($3.14B vs $2.87B market cap).
  • •Both run net losses; DYN's is the smaller (0.00% vs -14191.20% net margin).

Metrics side by side

Valuation

MetricDNLIDYN
P/S ratio870.59N/A
P/B ratio3.764.09

Profitability

MetricDNLIDYN
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin-14191.20%0.00%
ROE-61.24%-73.97%
ROIC-50.82%-58.28%

Growth (annualized)

MetricDNLIDYN
Revenue CAGR (5Y)20.68%N/A
Total return CAGR (5Y)-16.91%-0.38%

Frequently asked

How have DNLI and DYN total returns compared?
Over the past 5 years, DNLI delivered -16.91% and DYN delivered -0.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.